Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Nascent RNA sequencing (PRO-seq) after estrogen treatment in T47D cells

ABSTRACT: Nascent RNA sequencing (PRO-seq) after estrogen treatment in T47D cells

PROVIDER: PRJNA764248 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15944159_1.fastq.gz	Fastqsanger.gz
	SRR15944159_2.fastq.gz	Fastqsanger.gz
	SRR15944160_1.fastq.gz	Fastqsanger.gz
	SRR15944160_2.fastq.gz	Fastqsanger.gz
	SRR15944161_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Nascent RNA sequencing (PRO-seq) after estrogen treatment in T47D cells

Project description:This experiment identifies the primary estrogen response genes in T47D cells.

2021-09-17 | GSE184378 | GEO

Nascent RNA sequencing (PRO-seq) after various treatments in T47D cells

Project description:This experiment identifies the primary estrogen response genes in T47D cells.

2023-12-21 | GSE251785 | GEO

Nascent RNA sequencing (PRO-seq) after various treatments in T47D cells

Project description:Nascent RNA sequencing (PRO-seq) after various treatments in T47D cells

| PRJNA1055459 | ENA

Nascent RNA sequencing (PRO-seq) after 200nM romidepsin treatment of H9 cells

Project description:Nascent RNA sequencing (PRO-seq) after 200nM romidepsin treatment of H9 cells

2019-12-12 | GSE141843 | GEO

Estrogen receptor agonism/antagonism in T47D cells

Project description:Estrogen receptor agonism/antagonism in T47D cells

| PRJNA1055455 | ENA

Nascent RNA sequencing (PRO-seq) after 200nM romidepsin treatment of H9 cells

Project description:Nascent RNA sequencing (PRO-seq) after 200nM romidepsin treatment of H9 cells

| PRJNA594951 | ENA

T47D cell line transfected with various ESR1 fusion genes (or with estrogen treatment), vs. YFP transfection alone

Project description:Gene expression profiling of the downstream transcriptional changes induced by ESR1 fusion genes observed in human breast tumors resistant to hormone therapy Experimental T47D cells stably expressing ESR1 fusion genes (or T47D cells treated with estradiol) vs. T47D cells expressing YFP

2015-06-12 | E-GEOD-69774 | biostudies-arrayexpress

T47D shNT versus T47D shRON

Project description:T47D shNT versus T47D shRON

| PRJNA682172 | ENA

Differential expression levels of mRNAs in tamoxifen-sensitive T47D versus tamoxifen-resistant T47D (T47DR) human breast cancer cells

Project description:Tamoxifen is the most widely used antiestrogen in patients with estrogen receptor (ER) positive breast cancer . However, less than half of patients benefit from tamoxifen treatment and 30-50% acquire resistance and the disease progresses. Resistance to tamoxifen is a serious problem in breast cancer therapy and major efforts are underway to find out underlying mechanisms. To find out the differential expression levels of mRNAs in tamoxifen-sensitive T47D versus tamoxifen-resistant T47D (T47DR) human breast cancer cells, T47DR (tamoxifen-resistant) cell line was established from T47D cells after the following continuous exposure to 1 μmol/L 4-Hydroxytamoxifen (H7904, Sigma, USA) for more than 6 months.Thousands of significantly different mRNA expression levels were found and analysed. Our study provides a reference data for the study of tamoxifen resistance .

2020-06-01 | GSE129544 | GEO

Annotation of estrogen-regulated enhancer RNAs [PRO-cap]

Project description:Annotation of estrogen-regulated enhancer RNAs [PRO-cap]

| PRJNA732438 | ENA